The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Intravenous (IV) Ibuprofen Market Research Report 2024

Global Intravenous (IV) Ibuprofen Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1535327

No of Pages : 90

Synopsis
Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.
The global Intravenous (IV) Ibuprofen market was valued at US$ 7046.7 million in 2023 and is anticipated to reach US$ 15400 million by 2030, witnessing a CAGR of 11.3% during the forecast period 2024-2030.
North American market for Intravenous (IV) Ibuprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intravenous (IV) Ibuprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intravenous (IV) Ibuprofen include Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, Sandor Medicaids, PT. Soho Industri Pharmasi, Germin MED, Grifols, Gloria Pharmaceuticals and Al Nabeel International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Ibuprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Ibuprofen.
Report Scope
The Intravenous (IV) Ibuprofen market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous (IV) Ibuprofen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous (IV) Ibuprofen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca
Segment by Type
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose
Segment by Application
Pain
Fever
Inflammation
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous (IV) Ibuprofen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous (IV) Ibuprofen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Intravenous (IV) Ibuprofen Market Overview
1.1 Product Overview and Scope of Intravenous (IV) Ibuprofen
1.2 Intravenous (IV) Ibuprofen Segment by Type
1.2.1 Global Intravenous (IV) Ibuprofen Market Value Comparison by Type (2024-2030)
1.2.2 100 mg Dose
1.2.3 200 mg Dose
1.2.4 400 mg Dose
1.2.5 800 mg Dose
1.3 Intravenous (IV) Ibuprofen Segment by Application
1.3.1 Global Intravenous (IV) Ibuprofen Market Value by Application: (2024-2030)
1.3.2 Pain
1.3.3 Fever
1.3.4 Inflammation
1.4 Global Intravenous (IV) Ibuprofen Market Size Estimates and Forecasts
1.4.1 Global Intravenous (IV) Ibuprofen Revenue 2019-2030
1.4.2 Global Intravenous (IV) Ibuprofen Sales 2019-2030
1.4.3 Global Intravenous (IV) Ibuprofen Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravenous (IV) Ibuprofen Market Competition by Manufacturers
2.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravenous (IV) Ibuprofen Average Price by Manufacturers (2019-2024)
2.4 Global Intravenous (IV) Ibuprofen Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous (IV) Ibuprofen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous (IV) Ibuprofen, Product Type & Application
2.7 Intravenous (IV) Ibuprofen Market Competitive Situation and Trends
2.7.1 Intravenous (IV) Ibuprofen Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous (IV) Ibuprofen Players Market Share by Revenue
2.7.3 Global Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous (IV) Ibuprofen Retrospective Market Scenario by Region
3.1 Global Intravenous (IV) Ibuprofen Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravenous (IV) Ibuprofen Global Intravenous (IV) Ibuprofen Sales by Region: 2019-2030
3.2.1 Global Intravenous (IV) Ibuprofen Sales by Region: 2019-2024
3.2.2 Global Intravenous (IV) Ibuprofen Sales by Region: 2025-2030
3.3 Global Intravenous (IV) Ibuprofen Global Intravenous (IV) Ibuprofen Revenue by Region: 2019-2030
3.3.1 Global Intravenous (IV) Ibuprofen Revenue by Region: 2019-2024
3.3.2 Global Intravenous (IV) Ibuprofen Revenue by Region: 2025-2030
3.4 North America Intravenous (IV) Ibuprofen Market Facts & Figures by Country
3.4.1 North America Intravenous (IV) Ibuprofen Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravenous (IV) Ibuprofen Sales by Country (2019-2030)
3.4.3 North America Intravenous (IV) Ibuprofen Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous (IV) Ibuprofen Market Facts & Figures by Country
3.5.1 Europe Intravenous (IV) Ibuprofen Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravenous (IV) Ibuprofen Sales by Country (2019-2030)
3.5.3 Europe Intravenous (IV) Ibuprofen Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous (IV) Ibuprofen Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous (IV) Ibuprofen Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravenous (IV) Ibuprofen Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravenous (IV) Ibuprofen Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravenous (IV) Ibuprofen Market Facts & Figures by Country
3.7.1 Latin America Intravenous (IV) Ibuprofen Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravenous (IV) Ibuprofen Sales by Country (2019-2030)
3.7.3 Latin America Intravenous (IV) Ibuprofen Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous (IV) Ibuprofen Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous (IV) Ibuprofen Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intravenous (IV) Ibuprofen Sales by Type (2019-2030)
4.1.1 Global Intravenous (IV) Ibuprofen Sales by Type (2019-2024)
4.1.2 Global Intravenous (IV) Ibuprofen Sales by Type (2025-2030)
4.1.3 Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2019-2030)
4.2 Global Intravenous (IV) Ibuprofen Revenue by Type (2019-2030)
4.2.1 Global Intravenous (IV) Ibuprofen Revenue by Type (2019-2024)
4.2.2 Global Intravenous (IV) Ibuprofen Revenue by Type (2025-2030)
4.2.3 Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous (IV) Ibuprofen Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intravenous (IV) Ibuprofen Sales by Application (2019-2030)
5.1.1 Global Intravenous (IV) Ibuprofen Sales by Application (2019-2024)
5.1.2 Global Intravenous (IV) Ibuprofen Sales by Application (2025-2030)
5.1.3 Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2019-2030)
5.2 Global Intravenous (IV) Ibuprofen Revenue by Application (2019-2030)
5.2.1 Global Intravenous (IV) Ibuprofen Revenue by Application (2019-2024)
5.2.2 Global Intravenous (IV) Ibuprofen Revenue by Application (2025-2030)
5.2.3 Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous (IV) Ibuprofen Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cumberland Pharmaceuticals
6.1.1 Cumberland Pharmaceuticals Corporation Information
6.1.2 Cumberland Pharmaceuticals Description and Business Overview
6.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product Portfolio
6.1.5 Cumberland Pharmaceuticals Recent Developments/Updates
6.2 Alveda Pharmaceuticals
6.2.1 Alveda Pharmaceuticals Corporation Information
6.2.2 Alveda Pharmaceuticals Description and Business Overview
6.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product Portfolio
6.2.5 Alveda Pharmaceuticals Recent Developments/Updates
6.3 CSL Limited
6.3.1 CSL Limited Corporation Information
6.3.2 CSL Limited Description and Business Overview
6.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Limited Intravenous (IV) Ibuprofen Product Portfolio
6.3.5 CSL Limited Recent Developments/Updates
6.4 Sandor Medicaids
6.4.1 Sandor Medicaids Corporation Information
6.4.2 Sandor Medicaids Description and Business Overview
6.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Product Portfolio
6.4.5 Sandor Medicaids Recent Developments/Updates
6.5 PT. Soho Industri Pharmasi
6.5.1 PT. Soho Industri Pharmasi Corporation Information
6.5.2 PT. Soho Industri Pharmasi Description and Business Overview
6.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2019-2024)
6.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product Portfolio
6.5.5 PT. Soho Industri Pharmasi Recent Developments/Updates
6.6 Germin MED
6.6.1 Germin MED Corporation Information
6.6.2 Germin MED Description and Business Overview
6.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Germin MED Intravenous (IV) Ibuprofen Product Portfolio
6.6.5 Germin MED Recent Developments/Updates
6.7 Grifols
6.6.1 Grifols Corporation Information
6.6.2 Grifols Description and Business Overview
6.6.3 Grifols Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Grifols Intravenous (IV) Ibuprofen Product Portfolio
6.7.5 Grifols Recent Developments/Updates
6.8 Gloria Pharmaceuticals
6.8.1 Gloria Pharmaceuticals Corporation Information
6.8.2 Gloria Pharmaceuticals Description and Business Overview
6.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product Portfolio
6.8.5 Gloria Pharmaceuticals Recent Developments/Updates
6.9 Al Nabeel International
6.9.1 Al Nabeel International Corporation Information
6.9.2 Al Nabeel International Description and Business Overview
6.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Product Portfolio
6.9.5 Al Nabeel International Recent Developments/Updates
6.10 Laboratorios Valmorca
6.10.1 Laboratorios Valmorca Corporation Information
6.10.2 Laboratorios Valmorca Description and Business Overview
6.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Product Portfolio
6.10.5 Laboratorios Valmorca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous (IV) Ibuprofen Industry Chain Analysis
7.2 Intravenous (IV) Ibuprofen Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous (IV) Ibuprofen Production Mode & Process
7.4 Intravenous (IV) Ibuprofen Sales and Marketing
7.4.1 Intravenous (IV) Ibuprofen Sales Channels
7.4.2 Intravenous (IV) Ibuprofen Distributors
7.5 Intravenous (IV) Ibuprofen Customers
8 Intravenous (IV) Ibuprofen Market Dynamics
8.1 Intravenous (IV) Ibuprofen Industry Trends
8.2 Intravenous (IV) Ibuprofen Market Drivers
8.3 Intravenous (IV) Ibuprofen Market Challenges
8.4 Intravenous (IV) Ibuprofen Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’